Document:

Amendment to the 2011 Equity Incentive Plan

 Exhibit 10.7.1 
 WHITEGLOVE HEALTH, INC. 
 AMENDMENT NO. 1 TO 2011 EQUITY INCENTIVE PLAN

 The 2011 Equity Incentive Plan of WhiteGlove Health, Inc. (the “2011 Plan”) is hereby amended,
effective as of June 17, 2011, as follows: 
 1. The first sentence of Section 1.3(a) of Article I of the
2011 Plan is hereby amended to be read in its entirety as follows: 
 The maximum number of shares of Common Stock that may
be issued under the Plan shall be 350,000 shares, plus (1) any shares of Common Stock that, as of the Registration Date, have been reserved but not issued pursuant to any awards granted under the Company’s 2007 Stock Option/Stock Issuance
Plan, as amended (the “Existing Plan”) and are not subject to any awards granted thereunder, and (2) any shares of Common Stock subject to stock options or similar awards granted under the Existing Plan that
expire or otherwise terminate without having been exercised in full and shares of Common Stock pursuant to awards granted under the Existing Plan that are forfeited to or repurchased by the Company, with the maximum number of shares of Common Stock
to be added to the Plan pursuant to clauses (1) and (2) equal to 2,367,250 shares of Common Stock. 
 2. Except as
modified by this Amendment, all the terms and provisions of the Plan shall continue in full force and effect. 
 IN WITNESS
WHEREOF, WhiteGlove Health, Inc. has caused this Amendment to be executed on its behalf by its duly authorized officer as of June 17, 2011. 
  

	
	WHITEGLOVE HEALTH, INC.
	
	/s/    William J. Kerley    
	 William J. Kerley
 Chief
Financial OfficerAmendment to the 2011 Equity Incentive Plan

 Exhibit 10.7.2 
 WHITEGLOVE HEALTH, INC. 
 AMENDMENT NO. 2 TO 2011 EQUITY INCENTIVE PLAN

 The 2011 Equity Incentive Plan of WhiteGlove Health, Inc. (the “2011 Plan”) is hereby amended,
effective as of July 18, 2011, as follows: 
 1. The first sentence of Section 1.3(a) of Article I of the
2011 Plan is hereby amended to be read in its entirety as follows: 
 The maximum number of shares of Common Stock that may
be issued under the Plan shall be 850,000 shares, plus (1) any shares of Common Stock that, as of the Registration Date, have been reserved but not issued pursuant to any awards granted under the Company’s 2007 Stock Option/Stock Issuance
Plan, as amended (the “Existing Plan”) and are not subject to any awards granted thereunder, and (2) any shares of Common Stock subject to stock options or similar awards granted under the Existing Plan that
expire or otherwise terminate without having been exercised in full and shares of Common Stock pursuant to awards granted under the Existing Plan that are forfeited to or repurchased by the Company, with the maximum number of shares of Common Stock
to be added to the Plan pursuant to clauses (1) and (2) equal to 2,367,250 shares of Common Stock. 
 2. Except as
modified by this Amendment, all the terms and provisions of the Plan shall continue in full force and effect. 
 IN WITNESS
WHEREOF, WhiteGlove Health, Inc. has caused this Amendment to be executed on its behalf by its duly authorized officer as of July 18, 2011. 
  

	
	WHITEGLOVE HEALTH, INC.
	
	/s/    William J. Kerley    
	 William J. Kerley
 Chief
Financial OfficerDirector Agreement between the Registrant and Leslie Norwalk

 Exhibit 10.24 
 WHITEGLOVE HOUSE CALL HEALTH 
 April 30, 2011 
 Ms. Leslie Norwalk 

7025 Arbor Lane 
 McLean, VA 22101 

Dear Leslie, 
 I would like to take this
opportunity to thank you for agreeing to become part of WhiteGlove’s Board of Directors. Your experience and insight will guide us to meeting our objective of changing healthcare on a national level by lowering the cost of healthcare while
improving the consumer experience. 
 Your annual (every twelve months commencing April 26th) compensation for your participation on the Board will be the
following: 
  

	 	•	 	 $30,000 in total, paid in twelve equal monthly payments; 

 

	 	•	 	 $5,000 per committee you participate on; and 

  

	 	•	 	 A certain number of restricted shares equal to $40,000 in FMV at time of stock grant where the shares vest over a twelve (12) month period from
the date of the stock grant at one twelfth (12th) of the total shares granted each calendar month. 

 WhiteGlove will
also reimburse reasonable travel expenses for travel as required for your participation in meetings and other events relevant to your participation on the Board. This will supercede any prior arrangements with WhiteGlove. 

As I indicated to you, in the unlikely event WhiteGlove was unable to complete its public offering in the upcoming months, then the board composition
would revert back to its structure as a private company. 
 Thank you, once again, for agreeing to be an invaluable part of WhiteGlove’s
success as a member of the Board. 
  

	
	 Sincerely,

	
	 Robert Fabbio

	
	 Robert Fabbio

	 Chief Executive Officer and President

  

			
	Please sign below to accept this offer.
		
	Accepted:	 	 /s/ Leslie Norwalk

		 	May 1, 2011

 Corporate Headquarters: 5300 Bee Cave Rd., Bldg 1, STE 100, Austin, TX 78746 

www.whiteglove.comDirector Agreement between the Registrant and Jimmy Treybig

 Exhibit 10.25 
 WHITEGLOVE HOUSE CALL HEALTH 
 April 30, 2011 
 Mr. Jimmy Treybig 

10915 Bee Caves Rd 
 Austin, TX 78733 

Dear Jimmy, 
 I would like to take this
opportunity to thank you for agreeing to become part of WhiteGbve’s Board of Directors. Your experience and insight will guide us to meeting our objective of changing healthcare on a national level by lowering the cost of healthcare while
improving the consumer experience. 
 Your annual (every twelve months commencing April 26th) compensation for your participation on the Board will be the
following: 
  

	 	•	 	 $30,000 in total, paid in twelve equal monthly payments; 

 

	 	•	 	 $5,000 per committee you participate on; and 

  

	 	•	 	 A certain number of restricted shares equal to $40,000 in FMV at time of stock grant where the shares vest over a twelve (12) month period from
the date of the stock grant at one twelfth (12th) of the total shares granted each calendar month. 

 WhiteGlove will
also reimburse reasonable travel expenses for travel as required for your participation in meetings and other events relevant to your participation on the Board. This will supercede any prior arrangements with WhiteGlove. 

As I indicated to you, in the unlikely event WhiteGlove was unable to complete its public offering in the upcoming months, then the board composition
would revert back to its structure as a private company. 
 Thank you, once again, for agreeing to be an invaluable part of WhiteGlove’s
success as a member of the Board. 
  

	
	Sincerely,
	
	Robert Fabbio
	
	Robert Fabbio
	Chef Executive Officer and President

  

					
	Please sign below to accept the offer.
			
	Accepted:	 	 /s/ James G. Treybig
	 	5/9/11

 Corporate Headquarters: 5300 Bee Cave Rd., Bldg 1, STE 100, Austin, TX 78746  

www.whiteglove.comDirector Agreement between the Registrant and Gary Mecklenburg

 Exhibit 10.26 
 WHITEGLOVE HOUSE CALL HEALTH 
 April 30, 2011 
 Mr. Gary Mecklenburg 

3500 Topping Road 
 Madison, WI 53705 

Dear Gary, 
 I would like to take this
opportunity to thank you for agreeing to become part of WhiteGlove’s Board of Directors. Your experience and insight will guide us to meeting our objective of changing healthcare on a national level by lowering the cost of healthcare while
improving the consumer experience. 
 Your annual (every twelve months commencing April 26th) compensation for your participation on the Board will be the
following: 
  

	 	•	 	 $30,000 in total, paid in twelve equal monthly payments; 

 

	 	•	 	 $5,000 per committee you participate on; and 

  

	 	•	 	 A certain number of restricted shares equal to $40,000 in FMV at time of stock grant where the shares vest over a twelve (12) month period from
the date of the stock grant at one twelfth (12th) of the total shares granted each calendar month. 

 WhiteGlove will
also reimburse reasonable travel expenses for travel as required for your participation in meetings and other events relevant to your participation on the Board. This will supercede any prior arrangements with WhiteGlove. 

As I indicated to you, in the unlikely event WhiteGlove was unable to complete its public offering in the upcoming months, then the board composition
would revert back to its structure as a private company. 
 Thank you, once again, for agreeing to be an invaluable part of WhiteGlove’s
success as a member of the Board. 
 Sincerely, 
 Robert Fabbio 
 Robert Fabbio 
 Chief Executive Officer and President 
 Please sign below to accept this offer. 

 

			
	Accepted:	 	 /s/ Gary Mecklenburg

		
	Date:	 	 May 2, 2011

 Corporate Headquarters: 5300 Bee Cave Rd., Bldg 1, STE 100, Austin, TX 78746 

www.whiteglove.comDirector Agreement between the Registrant and Ed Ateyeh

 Exhibit 10.27 
 WHITEGLOVE HOUSE CALL HEALTH 
 April 30, 2011 
 Mr. Ed Ateyeh 
 4410 Michaels Cove 
 Austin, TX 78746 
 Dear Ed, 
 I would like to take this opportunity to thank you for agreeing to become part of
WhiteGlove’s Board of Directors. Your experience and insight will guide us to meeting our objective of changing healthcare on a national level by lowering the cost of healthcare while improving the consumer experience. 

Your annual (every twelve months commencing April 26th) compensation for your participation on the Board will be the following: 

 

	 	•	 	 $30,000 in total, paid in twelve equal monthly payments; 

 

	 	•	 	 $5,000 per committee you participate on; and 

  

	 	•	 	 A certain number of restricted shares equal to $40,000 in FMV at time of stock grant where the shares vest over a twelve (12) month period from
the date of the stock grant at one twelfth (12th) of the total shares granted each calendar month. 

 WhiteGlove will
also reimburse reasonable travel expenses for travel as required for your participation in meetings and other events relevant to your participation on the Board. This will supercede any prior arrangements with WhiteGlove. 

As I indicated to you, in the unlikely event WhiteGlove was unable to complete its public offering in the upcoming months, then the board composition
would revert back to its structure as a private company. 
 Thank you, once again, for agreeing to be an invaluable part of WhiteGlove’s
success as a member of the Board. 
 Sincerely, 
 Robert Fabbio 
 Robert Fabbio 
 Chief Executive Officer and President 
 Please sign below to accept this offer. 

 

			
	Accepted :	 	 /s/ Ed Ateyeh

		
	Date:	 	 May 2, 2011

 Corporate Headquarters: 5300 Bee Cave Rd., Bldg 1, STE 100, Austin, TX 78746 

www.whiteglove.com

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00192-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00192-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00192-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00192-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00192-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00192-of-00352.parquet"}]]